Drugs / Licensed TdaP booster vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01529645 Comparator | Mar → Jul 2012 | diphtheria, pertussis, tetanus | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licensed TdaP booster vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01529645 ↗ |
| Modality | Vaccine | “Licenced TdaP booster vaccine was administered intramuscularly in the upper deltoid region of the subject's non-dominant arm.” NCT01529645 ↗ |
| Route | Intramuscular | “administered intramuscularly in the upper deltoid region” NCT01529645 ↗ |